Literature DB >> 19588484

Overexpression of Sp1 leads to p53-dependent apoptosis in cancer cells.

Jian-Ying Chuang1, Chien-Hsing Wu, Ming-Derg Lai, Wen-Chang Chang, Jan-Jong Hung.   

Abstract

Numerous studies have documented that Sp1 expression level were elevated in various human cancers. However, the promoters of many pro-apoptotic genes have been found to contain the Sp1 binding elements and are activated by Sp1 overexpression. To better understand the role and the mechanism of increased Sp1 levels on apoptosis, we used adenovirus to ectopically express GFP-Sp1 protein in various cancer cell lines. First, in HeLa and A549 cells, we found that Sp1 overexpression suppressed the cell growth and increased the detection of sub-G1 fraction, caspase-3 cleavage, and annexin-V signal revealed that apoptosis occurred. Furthermore, when cells entered the mitotic stage, the cell apoptosis was induced by Sp1 overexpression through affecting mitotic chromatin packaging. We also verified that p53 protein was accumulated and activated the p53-dependent apoptotic pathways in the wild-type p53 cells but not in the p53-mutated or p53-deleted cell lines when these cells were infected with adeno-GFP-Sp1 virus. In addition, A549 (p53(+/+)) cells could be protected from apoptosis under Sp1 overexpression when p53 was knockdown by p53 shRNA. Finally, H1299 (p53(-/-)) cell viability was significantly inhibited by adeno-GFP-Sp1 virus infection in the expression of p53. In conclusion, p53 was an essential factor for Sp1 overexpression-induced apoptotic cell death in transforming cells. (c) 2009 UICC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19588484     DOI: 10.1002/ijc.24563

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  29 in total

1.  Sp1 phosphorylation by cyclin-dependent kinase 1/cyclin B1 represses its DNA-binding activity during mitosis in cancer cells.

Authors:  J-Y Chuang; S-A Wang; W-B Yang; H-C Yang; C-Y Hung; T-P Su; W-C Chang; J-J Hung
Journal:  Oncogene       Date:  2012-01-23       Impact factor: 9.867

2.  Arsenic trioxide downregulates specificity protein (Sp) transcription factors and inhibits bladder cancer cell and tumor growth.

Authors:  Indira Jutooru; Gayathri Chadalapaka; Sandeep Sreevalsan; Ping Lei; Rola Barhoumi; Robert Burghardt; Stephen Safe
Journal:  Exp Cell Res       Date:  2010-05-08       Impact factor: 3.905

3.  MPTP's pathway of toxicity indicates central role of transcription factor SP1.

Authors:  Alexandra Maertens; Thomas Luechtefeld; Andre Kleensang; Thomas Hartung
Journal:  Arch Toxicol       Date:  2015-04-08       Impact factor: 5.153

4.  Physcion, a naturally occurring anthraquinone derivative, induces apoptosis and autophagy in human nasopharyngeal carcinoma.

Authors:  Ming-Jie Pang; Zhun Yang; Xing-Lin Zhang; Zhao-Fang Liu; Jun Fan; Hong-Ying Zhang
Journal:  Acta Pharmacol Sin       Date:  2016-10-03       Impact factor: 6.150

5.  Sp1 is over-expressed in nasopharyngeal cancer and is a poor prognostic indicator for patients receiving radiotherapy.

Authors:  Jun Wang; Min Kang; Yu-Tao Qin; Zhu-Xin Wei; Jing-Jian Xiao; Ren-Sheng Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

6.  Natural diterpenes from coffee, cafestol and kahweol induce apoptosis through regulation of specificity protein 1 expression in human malignant pleural mesothelioma.

Authors:  Kyung-Ae Lee; Jung-Il Chae; Jung-Hyun Shim
Journal:  J Biomed Sci       Date:  2012-06-26       Impact factor: 8.410

7.  Sp1 expression regulates lung tumor progression.

Authors:  T-I Hsu; M-C Wang; S-Y Chen; Y-M Yeh; W-C Su; W-C Chang; J-J Hung
Journal:  Oncogene       Date:  2011-12-12       Impact factor: 9.867

8.  Evaluation of the selenotranscriptome expression in two hepatocellular carcinoma cell lines.

Authors:  Stefano Guariniello; Giovanni Di Bernardo; Giovanni Colonna; Marcella Cammarota; Giuseppe Castello; Susan Costantini
Journal:  Anal Cell Pathol (Amst)       Date:  2015-06-23       Impact factor: 2.916

9.  Cryptolepine inhibits hepatocellular carcinoma growth through inhibiting interleukin-6/STAT3 signalling.

Authors:  Seth A Domfeh; Patrick W Narkwa; Osbourne Quaye; Kwadwo A Kusi; Gordon A Awandare; Charles Ansah; Alimatu Salam; Mohamed Mutocheluh
Journal:  BMC Complement Med Ther       Date:  2021-06-02

10.  Cloning and characterization of the human USP22 gene promoter.

Authors:  Jianjun Xiong; Xiangxin Che; Xueqin Li; Huan Yu; Zhen Gong; Weidong Li
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.